Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase I Study of E7050 in Solid Tumors
jRCT2080221558Phase 1
- Sponsor
- Eisai Co., Ltd.
- Start
- Sep 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of Golvatinib in Nonhematologic neoplasms, sponsored by Eisai Co., Ltd.
02
Drugs
Golvatinib
03
Conditions
Nonhematologic neoplasms
Beyond the preview
Go deeper on jRCT2080221558.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080221558.